Ascend Capital’s Cambrex Corporation CBM Stock Holding History

Ascend Capital’s Portfolio CBM Stock Details CBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-105,305	Closed	-$5.8M	–	203
2017 Q1	$5.8M	Buy	+105,305	New	+$5.62M	0.26%	95

Other funds holding CBM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Ascend Capital's CBM Position: Q2 2017 in Review

Ascend Capital sold out of Cambrex Corporation (CBM) in Q2 2017, closing a stake of 105,305 shares — an estimated $5.8M sold.

Ascend Capital first reported a position in CBM in Q1 2017 and held it in 1 quarter. The position peaked at $5.8M in Q1 2017. 244 funds tracked by Wall St. Rank hold CBM as of Q2 2017.

Ascend Capital reported no remaining Cambrex Corporation position as of Q2 2017 after selling out during the quarter.
Ascend Capital sold 105,305 Cambrex Corporation shares in Q2 2017, an estimated $5.8M.
Ascend Capital first reported a position in Cambrex Corporation in Q1 2017 and held it in 1 quarter.
Ascend Capital's Cambrex Corporation position peaked at $5.8M in Q1 2017.
244 funds tracked by Wall St. Rank held Cambrex Corporation as of Q2 2017.

Based on Ascend Capital's 13F filing for Q2 2017, filed 11 Aug 2017.